Zisis Vasileios, Venou Maria, Poulopoulos Athanasios, Andreadis Dimitrios
Aristotle University of Thessaloniki, School of Dentistry, Department of Oral Medicine/Pathology, Thessaloniki, Greece
Summary
Head and neck squamous cell carcinoma (HNSCC) belongs to the most frequent cancer subtypes in the world. Mutations due to genetic and chromosomal instability, syndromes such as Fanconi anemia and the Bloom syndrome, environmental risk factors such as tobacco smoking, alcohol and human papillomavirus infection (HPV) subtypes 16,18,31,33,35,52,58 are implicated in its pathogenesis. The HNSCC belongs to the solid tumors of epithelial origin and consists of stromal, inflammatory, cancer cells and most importantly a fraction of them, the cancer stem cells (CSCs). The identification of the CSCs through their biomarkers such as CD44, CD10, CD166, CD133, CD271, ALDH, Oct4, Nanog, Sox2 and Bmi1, the maintenance of their subpopulation through epithelial to mesenchymal transition, the role of HPV infection regarding their prognosis and of their microenvironment regarding their resistance to therapy, all constitute key elements that must be taken thoroughly into consideration in order to develop an effective targeted therapy. There are already therapies in place targeting specific related biomarkers, important biochemical pathways and growth factors. The aim of this literature review is to illustrate the treatment modalities available against the cancer stem cells of head and neck squamous cell carcinoma.
Keywords: cancer stem cells; oral cancer; oral cancer stem cells; head and neck cancer; HPV and cancer; cancer stem cells treatment
Reference
Biddle, A., Gammon, L., Liang, X., Costea, D.E., Mackenzie, I.C. (2016) Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma. EBioMedicine, 4: 138-145
Chen, D., Wu, M., Li, Y., Chang, I., Yuan, Q., Ekimyan-Salvo, M., et al. (2017) Targeting BMI1+ cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell, 20(5): 621-634
Chen, D., Wang, C. (2019) Targeting cancer stem cells in squamous cell carcinoma. Precision Clinical Medicine, 2(3): 152-165
de Moraes, F., Lourenço, S.V., Ianez, R., de Sousa, E.A., Silva, M.M. da C., Damascena, A.S. (2017) Expression of stem cell markers in oral cavity and oropharynx squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology, 123: 113-122
Elkashty, O.A., Ashry, R., Tran, S.D. (2019) Head and neck cancer management and cancer stem cells implication. Saudi Dental Journal, 31(4): 395-416
Gammon, L., MacKenzie, I.C. (2016) Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer. Journal of Oral Pathology & Medicine, 45(2): 77-82
Gemenetzidis, E., Gammon, L., Biddle, A., Emich, H., Mackenzie, I.C. (2015) Invasive oral cancer stem cells display resistance to ionising radiation. Oncotarget, 6(41): 43964-43977
Kaseb, H.O., Fohrer-Ting, H., Lewis, D.W., Lagasse, E., Gollin, S.M. (2016) Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Experimental Cell Research, 348(1): 75-86
Kaseb, H.O., Lewis, D.W., Saunders, W.S., Gollin, S.M. (2016) Cell division patterns and chromosomal segregation defects in oral cancer stem cells. Genes, Chromosomes and Cancer, 55(9): 694-709
Kerk, S.A., Finkel, K.A., Pearson, A.T., Warner, K.A., Zhang, Z., Nör, F., et al. (2017) 5T4-targeted therapy ablates cancer stem cells and prevents recurrence of head and neck squamous cell carcinoma. Clinical Cancer Research, 23(10): 2516-2527
Ketkaew, Y., Osathanon, T., Pavasant, P., Sooampon, S. (2017) Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Archives of Oral Biology, 74: 69-74
Kim, J., Shin, J.H., Chen, C., Cruz, L., Farnebo, L., Yang, J., Borges, P., Kang, G., Mochly-Rosen, D., Sunwoo, J.B. (2017) Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor. Oncotarget, 8(32): 52345-52356
Lazarević, M., Milosević, M., Trisić, D., Toljić, B., Simonović, J., Nikolić, N., et al. (2018) Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma. JBUON, 23: 1686-1692
Lee, M.Y., Lufkin, T. (2012) Development of the ‘three-step macs’: A novel strategy for isolating rare cell populations in the absence of known cell surface markers from complex animal tissue. Journal of Biomolecular Techniques: JBT, 23(2): 69-77
Liang, G., Li, S., Du, W., Ke, Q., Cai, J., Yang, J. (2017) Hypoxia regulates CD44 expression via hypoxia-inducible factor-1a in human gastric cancer cells. Oncology Letters, 13(2): 967-972
Lim, Y.C., Kang, H.J., Moon, J.H. (2014) C-met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell. Oral Oncology, 50(7): 633-639
Linge, A., Lohaus, F., Löck, S., Nowak, A., Gudziol, V., Valentini, C., et al. (2016) HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radi. Radiotherapy and Oncology, 121(3): 364-373
Linge, A., Löck, S., Gudziol, V., Nowak, A., Lohaus, F., von Neubeck, C., et al. (2016) Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: A multicenter study of the DKTK-ROG. Clinical Cancer Research, 22(11): 2639-2649
Liu, J., Pan, S., Hsieh, M.H., Ng, N., Sun, F., Wang, T., et al. (2013) Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proceedings of the National Academy of Sciences, 110(50): 20224-20249
Liu, W., Feng, J.Q., Shen, X.M., Wang, H.Y., Liu, Y., Zhou, Z.T. (2012) Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: A long-term follow-up study. Cancer, 118(6): 1693-1700
López-Lázaro, M. (2016) A local mechanism by which alcohol consumption causes cancer. Oral Oncology, 62: 149-152
McDermott, S.C., Rodriguez-Ramirez, C., McDermott, S.P., Wicha, M.S., Nör, J.E. (2018) FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. Oncotarget, 9(38): 25148-25165
Méry, B., Guy, J.B., Espenel, S., Wozny, A.S., Simonet, S., Vallard, A. (2016) Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives. World Journal of Stem Cells, 8(1): 13-21
Modur, V., Thomas-Robbins, K., Rao, K. (2015) HPV and CSC in HNSCC cisplatin resistance. Front Biosci (Elite ed), 7: 58-66
Moharil, R., Dive, A., Khandekar, S., Bodhade, A. (2017) Cancer stem cells: An insight. Journal of Oral and Maxillofacial Pathology, 21(3): 463-463
Naik, P.P., Das, D.N., Panda, P.K., Mukhopadhyay, S., Sinha, N., Praharaj, P.P., Agarwal, R., Bhutia, S.K. (2016) Implications of cancer stem cells in developing therapeutic resistance in oral cancer. Oral Oncology, 62: 122-135
Odenthal, J., Rijpkema, M., Bos, D., Wagena, E., Croes, H., Grenman, R., Boerman, O., Takes, R., Friedl, P. (2018) Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma. Scientific Reports, 8(1): 10467-10467
Peitzsch, C., Nathansen, J., Schniewind, S.I., Schwarz, F., Dubrovska, A. (2019) Cancer stem cells in head and neck squamous cell carcinoma: Identification, characterization and clinical implications. Cancers, 11(5): 616-616
Peng, C., Liao, Y., Lu, M., Yu, C., Yu, C.H., Chou, M. (2017) Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas. Journal of the Formosan Medical Association, 116(10): 782-789
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., Comoglio, P.M. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3(4): 347-361
Prince, M.E.P., Ailles, L.E. (2008) Cancer stem cells in head and neck squamous cell cancer. Journal of Clinical Oncology, 26(17): 2871-2875
Prince, M.E.P., Zhou, L., Moyer, J.S., Tao, H., Lu, L., Owen, J., Egenti, M., Zheng, F., Chang, A.E., Xia, J., Wolf, G., Wicha, M.S., Huang, S., Ren, X., Li, Q. (2016) Evaluation of the immunogenicity of ALDHhigh human head and neck squamous cell carcinoma cancer stem cells in vitro. Oral Oncology, 59: 30-42
Pullos, A.N., Castilho, R.M., Squarize, C.H. (2015) HPV infection of the head and neck region and its stem cells. Journal of Dental Research, 94(11): 1532-1543
Simple, M., Suresh, A., Das, D., Kuriakose, M.A. (2015) Cancer stem cells and field cancerization of oral squamous cell carcinoma. Oral Oncology, 51(7): 643-651
Sun, S., Liu, S., Duan, S.Z., Zhang, L., Zhou, H., Hu, Y., Zhou, X., Shi, C., Zhou, R., Zhang, Z. (2014) Targeting the c-Met/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas. Cancer Research, 74(24): 7546-7559
Sun, S., Wang, Z. (2011) Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. International Journal of Cancer, 129(10): 2337-2348
Tang, A.L., Hauff, S.J., Owen, J.H., Graham, M.P., Czerwinski, M.J., Park, J.J., Walline, H., Papagerakis, S., Stoerker, J., McHugh, J.B., Chepeha, D.B., Bradford, C.R., Carey, T.E., Prince, M.E. (2012) UM-SCC-104: A new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head & Neck, 34(10): 1480-1491
Wang, J., Wu, Y., Gao, W., Li, F., Bo, Y., Zhu, M., Fu, R., Liu, Q., Wen, S., Wang, B. (2017) Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell lines. Journal of Cancer, 8(3): 497-506
Wang, S.S., Jiang, J., Liang, X.H., Tang, Y.L. (2015) Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther, 8: 2973-2980
Wang, S.J., Wong, G., de Heer, A.M., Xia, W., Bourguignon, L.Y.W. (2009) CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope, 119(8): 1518-1530
Yoshihama, R., Yamaguchi, K., Imajyo, I., Mine, M., Hiyake, N., Akimoto, N., Kobayashi, Y., Chigita, S., Kumamaru, W., Kiyoshima, T., Mori, Y., Sugiura, T. (2016) Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma. Oncology Letters, 11(2): 1435-1446
Balkan Journal of Dental Medicine, 2021, vol. 25, br. 2, str. 73-79